16 | Imatinib Mesylate (Gleevec)FDA Link
12/2021
-
03/2009 |
10 | CateninsIBA
10/2021
-
01/2014 |
10 | Proteins (Proteins, Gene)FDA Link
01/2020
-
05/2005 |
7 | Tyrosine Kinase InhibitorsIBA
09/2021
-
04/2012 |
6 | Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2021
-
01/2007 |
5 | NiclosamideFDA Link
01/2020
-
03/2010 |
5 | triptolideIBA
06/2010
-
03/2009 |
5 | Farnesyltranstransferase (Farnesyltransferase)IBA
10/2008
-
05/2005 |
4 | celastrol methyl esterIBA
12/2021
-
05/2010 |
4 | bcr-abl Fusion ProteinsIBA
01/2018
-
05/2010 |
4 | Paclitaxel (Taxol)FDA LinkGeneric
02/2010
-
06/2005 |
3 | Histone Deacetylase InhibitorsIBA
01/2022
-
03/2016 |
3 | ponatinibIBA
10/2021
-
01/2014 |
3 | N- (5- (((5- (1,1- dimethylethyl)- 2- oxazolyl)methyl)thio)- 2- thiazolyl)- 4- piperidinecarboxamideIBA
10/2021
-
04/2012 |
3 | AnthelminticsIBA
11/2020
-
02/2017 |
3 | pyrvinium (Vankin)FDA Link
11/2020
-
10/2017 |
3 | GSK-2816126IBA
01/2020
-
01/2017 |
3 | Antineoplastic Agents (Antineoplastics)IBA
01/2017
-
10/2005 |
3 | Reactive Oxygen Species (Oxygen Radicals)IBA
06/2012
-
05/2005 |
3 | manumycinIBA
10/2008
-
06/2005 |
2 | Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA
01/2022
-
10/2021 |
2 | salinomycinIBA
03/2021
-
11/2019 |
2 | S116836IBA
01/2020
-
07/2014 |
2 | Phosphotransferases (Kinase)IBA
01/2017
-
05/2014 |
2 | tenovin-6IBA
03/2016
-
04/2015 |
2 | Sirtuin 1IBA
03/2016
-
04/2015 |
2 | Growth Factor ReceptorsIBA
11/2014
-
11/2009 |
2 | STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
12/2010
-
01/2010 |
2 | NF-kappa B (NF-kB)IBA
05/2010
-
03/2010 |
2 | Oncogene Proteins (Oncogene Protein)IBA
11/2009
-
09/2005 |
1 | Harmine (Telepathine)IBA
12/2023 |
1 | Carbolines (Beta-Carbolines)IBA
12/2023 |
1 | RNA Precursors (Precursor, mRNA)IBA
01/2023 |
1 | Lipid PeroxidesIBA
01/2023 |
1 | Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2022 |
1 | Collagen Type I (Type I Collagen)IBA
12/2021 |
1 | human PRMT2 proteinIBA
10/2021 |
1 | Factor V (Coagulation Factor V)IBA
10/2021 |
1 | X-Box Binding Protein 1IBA
09/2021 |
1 | Small Interfering RNA (siRNA)IBA
01/2020 |
1 | Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2019 |
1 | Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2019 |
1 | GTP Phosphohydrolases (GTPases)IBA
01/2019 |
1 | Cytochromes c (Cytochrome c)IBA
04/2018 |
1 | pevonedistatIBA
01/2018 |
1 | artemisinin (artemisinine)IBA
01/2018 |
1 | Antimalarials (Antimalarial Agents)IBA
01/2018 |
1 | ArtesunateIBA
01/2018 |
1 | Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2017 |
1 | palbociclibIBA
01/2017 |
1 | Cyclin-Dependent Kinase 4IBA
01/2017 |
1 | CyclinsIBA
01/2017 |
1 | MethyltransferasesIBA
10/2016 |
1 | Histone Deacetylases (Histone Deacetylase)IBA
03/2016 |
1 | CytokinesIBA
08/2015 |
1 | Etoposide (VP 16)FDA LinkGeneric
04/2015 |
1 | Cytarabine (Cytosar-U)FDA LinkGeneric
04/2015 |
1 | Histones (Histone)IBA
01/2015 |
1 | 3-deazaneplanocinIBA
01/2015 |
1 | nilotinibFDA Link
01/2014 |
1 | Dasatinib (BMS 354825)FDA Link
01/2014 |
1 | S- 4- (4- ethyl- 7- isopropyl- 2,5,8,12- tetraoxo- 9- oxa- 3,6,13,18- tetraazabicyclo(13,2,1)octadec- 1- en- 10- yl)but- 3- enyl octanethioateIBA
01/2014 |
1 | TOR Serine-Threonine KinasesIBA
08/2013 |
1 | Alkylating AgentsIBA
08/2013 |
1 | EverolimusFDA Link
08/2013 |
1 | Bendamustine HydrochlorideFDA Link
08/2013 |
1 | DCC-2036IBA
01/2013 |